產品詳情
簡單介紹：
Anti-Relaxin 1 + Relaxin 2抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Relaxin 1 + Relaxin 2抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Relaxin 1 + Relaxin 2
Cat. Number:
Anti-Relaxin 1 + Relaxin 2抗體KL-7692R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Relaxin is a peptide hormone produced by the corpora lutea of ovaries during pregnancy in many mammalian species, including man. The secretion of the hormone into the blood stream just before parturition results in a marked Anti-Relaxin 1 + Relaxin 2抗體softening and lengthening of the pubic symphysis and a softening of the cervix, which facilitates the birth process. By inhibiting uterine contractions, relaxin may influence the timing of parturition. Like insulin, relaxin consists of two peptide chains, A and B, covalently linked by disulfide bonds. By further analogy to insulin, the two peptides are synthesized as a single-chain precursor polypeptide with the B chain at the NH2-terminus.
Also known as:
H1 antibody Preprorelaxin H1; Anti-Relaxin 1 + Relaxin 2抗體PreprorelaxinH1; Prorelaxin; Prorelaxin H1; ProrelaxinH1; Relaxin 1 (H1); Relaxin H1; Relaxin1; Relaxin-1; RelaxinH1; RLN 1; RLN1; RLX H1; RLXH 1; RLXH1; REL1_HUMAN; REL2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated syntheticAnti-Relaxin 1 + Relaxin 2抗體 peptide derived from human Relaxin 1 and Relaxin 2.
●
Predicted Molecular Weight: 18kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Relaxin 1 + Relaxin 2抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Relaxin 1 + Relaxin 2抗體
Optimal working dilutions must be determined by the end user.
